BioAdaptives, Inc.
BDPT
$0.00
$0.00-29.83%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.50K | 10.40K | 4.60K | 3.20K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.50K | 10.40K | 4.60K | 3.20K | -- |
| Cost of Revenue | 1.40K | 2.80K | 800.00 | 2.20K | -- |
| Gross Profit | 4.10K | 7.60K | 3.90K | 1.10K | -- |
| SG&A Expenses | 200.80K | 254.20K | 268.00K | 279.30K | 249.10K |
| Depreciation & Amortization | 1.50K | 1.50K | 1.50K | 1.00K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 203.70K | 258.50K | 270.30K | 282.40K | 249.10K |
| Operating Income | -198.20K | -248.10K | -265.70K | -279.20K | -249.10K |
| Income Before Tax | -111.10K | -823.30K | -379.50K | -157.90K | -197.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -111.10K | -823.30K | -379.50K | -157.90K | -197.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.10K | -823.30K | -379.50K | -157.90K | -197.10K |
| EBIT | -198.20K | -248.10K | -265.70K | -279.20K | -249.10K |
| EBITDA | -196.70K | -246.60K | -264.20K | -278.70K | -248.70K |
| EPS Basic | -0.01 | -0.07 | -0.04 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.04 | -0.03 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.07 | -0.04 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.04 | -0.03 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 12.01M | 12.03M | 10.24M | 9.53M | 9.05M |
| Average Diluted Shares Outstanding | 12.01M | 12.03M | 10.24M | 9.53M | 9.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |